Dr. Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda , currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth , renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care ; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology , academia , and public health advocacy .

Profile

• Scopus

Education

Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine ; he earned a B.A. with High Honors in Music from Bowdoin College (1977), pursued advanced coursework at MIT , and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole — blending physiology, neurology, and music to form a truly interdisciplinary academic foundation .

Experience

With over three decades in clinical neurology , Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013–present) ; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 , held multiple consultant roles across Vermont and New Hampshire , and co-directs the Electromyography Lab , establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments .

Awards & Recognitions

Dr. Stommel’s commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award (2011); he is a Fellow of the American Academy of Neurology and holds long-standing certifications in Electrodiagnostic Medicine and Neurology , complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education .

Research Interests

Dr. Stommel’s research revolves around neurodegenerative diseases, especially ALS , exploring environmental toxins , nanotechnology , and biomarkers to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology , he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues .